USAid shutdown isn’t just a humanitarian issue – it’s a threat to American interests

The website for the United States Agency for International Development (USAid), the world’s biggest aid donor, has gone dark.

Donald Trump’s new administration plans to place the autonomous agency under the control of the state department. The secretary of state, Marco Rubio, has now declared himself as head of the agency to “align” it with Trump’s priorities.

Several days ago, on January 26, Rubio said: “Every dollar we spend, every programme we fund, and every policy we pursue must be justified with the answer to three simple questions: Does it make America safer? Does it make America stronger? Does it make America more prosperous?”

But the decision to freeze USAid, which is part of Trump’s policy to put “America first”, places everyone at risk. Organisations that provide vital care for vulnerable people around the world are being forced to halt operations. The boss of one such organisation said: “People will die.”

Elon Musk, the world’s richest man and a close adviser to Trump, is playing an active role in the destruction of USAid. He has claimed – without providing any evidence – that the agency is “beyond repair”. “It needs to die,” Musk wrote on X.

Musk, who leads the newly formed Department of Government Efficiency (Doge), is gearing to cut trillions of dollars from the US budget. However, by seeing cuts to USAid as a solution, Trump and Musk are catering to an audience that has a fundamental misunderstanding about US foreign aid more generally.

Surveys demonstrate that Americans believe 25% of the federal budget is spent on foreign aid. In reality, the US gives about 0.2% of its gross national product (GNP), the total value of goods and services produced by a country, to foreign aid – or less than 1% of its federal budget. This is far below the UN target of 0.7% of GNP.

But, despite this, USAid provided 42% of all humanitarian aid globally in 2024. This included about US$72 billion (£58 billion) in aid in a wide range of areas, from helping people access clean water, sanitation, healthcare and energy, to providing disaster relief, shelter and food.

USAid also delivered programmes aimed at supporting democracy, civil society, economic development and landmine clearance in war zones, as well as working to prevent organised crime, terrorism and conflict. The gutting of USAid will have a profound impact on human security.

The Trump administration has granted a waiver for the continuation of “life-saving humanitarian assistance”. This includes a programme that helps 20 million people living with HIV/Aids access anti-retroviral drugs. But there are questions about the future of US Aids organisation, the President’s Emergency Plan for Aids Relief (Pepfar).

To date, over 43 million people worldwide have died from Aids. But one of the biggest success stories of the George W. Bush administration was its launch of Pepfar in 2003. The World Health Organization says that Pepfar, working in partnership with USAid, has saved 26 million lives.

Pepfar employs more than 250,000 doctors, nurses and other staff across 55 countries. One of the functions that USAid performs is ordering and procuring the drugs used by Pepfar to keep the millions infected with HIV alive. It remains to be seen whether federal payments to USAid’s locally run partner organisations will be stopped.

We are, in any case, likely to see an uptick in other infectious diseases. USAid had been working to prevent current outbreaks of mpox and Marburg virus from spreading beyond Africa. It is not clear what the future is for these programmes.

And USAid’s work with malaria, a disease that kills about 450,000 children under the age of five each year, is facing uncertainty. From 2000 to 2021, USAid’s work helped to prevent 7.6 million deaths from malaria. Also in doubt is USAid’s work to develop and implement the malaria vaccine, which was considered a gamechanger for combating the disease.

At the same time, USAid responds to an average of 65 natural disasters each year. In 2024 alone, it responded to 84 separate crises across 66 different countries. The government is letting go all of the staff important for implementing these types of programmes.

Dozens of senior USAid officials have been placed on leave, while contractors working on the agency’s programmes have been furloughed. Up to 3,000 aid workers in Washington DC could reportedly be laid off this week.

What Trump’s team misunderstand is that the work of USAid is also vital for preserving American interests. China, which has poured more than US$1 trillion of assistance into infrastructure projects in Asia, Africa, Europe and Latin America since 2013, will now be given an opportunity to exert more influence around the world. The void in US aid is a gift for China in the battle for soft power.

Global aid sector in disarray

Foreign aid relies on certainty and transparency about the future of aid programmes. But the Trump administration has offered little clarity while US foreign aid programmes are all being reviewed. One aid organisation referred to the situation as an “absolute dumpster fire” due to the uncertainty.

There have already been reports of total confusion in health clinics previously supported by USAid, which were shut down without warning. Africa will probably be the region most negatively affected. Local workers in healthcare-related projects on the continent will lose their jobs, while nurses, doctors and healthcare workers across clinics will be unable to continue their vital work.

The Democrats have claimed that Trump does not have the legal authority to eradicate a congressionally funded independent agency. They have said court challenges are already in motion and have pledged to try to block approval of Trump’s state department nominations until the shutdown is reversed.

Trump did try to cut US foreign aid during his first term, but Congress refused. He then tried – and ultimately failed – to freeze the flow of aid appropriated by Congress. This time, Trump is not bothering to play by the rules.

Natasha Lindstaedt does not work for, consult, own shares in or receive funding from any company or organisation that would benefit from this article, and has disclosed no relevant affiliations beyond their academic appointment.